این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
پنجشنبه 29 آبان 1404
مجله علوم اعصاب شفای خاتم
، جلد ۵، شماره ۲، صفحات ۳-۳
عنوان فارسی
O ۳:Therapeutic Potential of a Novel NMDA Receptor Subunit ۲B Antagonist in a Mouse Model of Autoimmune Neuroinflammation
چکیده فارسی مقاله
لطفاً به چکیده انگلیسی مراجعه شود.
کلیدواژههای فارسی مقاله
عنوان انگلیسی
O 3:Therapeutic Potential of a Novel NMDA Receptor Subunit 2B Antagonist in a Mouse Model of Autoimmune Neuroinflammation
چکیده انگلیسی مقاله
Glutamate-mediated excitotoxicity and neurodegeneration have been shown as pathophysiological hallmarks of multiple sclerosis (MS) and other autoimmune inflammatory CNS disorders. N‑Methyl‑D‑Aspartate (NMDA) receptors play a pivotal role in the mediation of neuronal glutamate excitotoxicity leading to cellular damage and apoptotic cell death. Current treatment approaches targeting glutamate excitotoxicity are unspecific and associated with severe adverse events due to the broad and important functions of NMDA receptors in the CNS. Hence, the present study investigates the neuroprotective potential of a novel specific NMDA receptor 2B (GluN2B) subunit antagonist. Prophylactic and therapeutic treatment with the GluN2B antagonist WMS14-10 (WMS) significantly ameliorated the disease course in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis (MOG-EAE), a murine model of MS. At disease maximum microglia from WMS treated mice showed decreased CD86 expression indicating reduced microglial activation. In agreement, activated microglia expressed GluN2B. Under restimulation with MOG splenocytes from WMS treated mice demonstrated decreased secretion of TNFα, INFγ and IL-17. In vitro WMS showed no significant effects on the function of T cells and macrophages/monocytes. However, incubation with WMS reduced lipopolysaccharide (LPS)-mediated secretion of cytokines like GM-CSF, IL-1α and TNFα by microglia. In conclusion, our results indicate that specific inhibition of GluN2B in microglia cells displays a newly identified pathway in neuroinflammatory degeneration. Ongoing studies aim at dissecting the underlying mechanisms and a putative additional effect on neuronal glutamate excitotoxicity.
کلیدواژههای انگلیسی مقاله
Therapeutic, Inflammatory, Mice
نویسندگان مقاله
سارا glumm | sarah glumm
department of translational neurology, university of münster, münster, germany
tobias ruck | tobias ruck
department of translational neurology, university of münster, münster, germany
dirk schepmann | dirk schepmann
department of pharmaceutical and medical chemistry, university of münster, münster, germany
heinz wiendl | heinz wiendl
department of translational neurology, university of münster, münster, germany
برنارد wünsch | bernhard wünsch
department of pharmaceutical and medical chemistry, university of münster, münster, germany
استفان bittner | stefan bittner
department of neurology, university of mainz, mainz, germany
sven g meuth | sven g meuth
department of translational neurology, university of münster, münster, germany
نشانی اینترنتی
http://shefayekhatam.ir/browse.php?a_code=A-10-24-821&slc_lang=en&sid=fa
فایل مقاله
اشکال در دسترسی به فایل - ./files/site1/rds_journals/337/article-337-385592.pdf
کد مقاله (doi)
زبان مقاله منتشر شده
fa
موضوعات مقاله منتشر شده
تحقیقات پایه در علوم اعصاب
نوع مقاله منتشر شده
مروری
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات